[{"Assets_0_Q2_USD":"4019965000.0","CIK":"1048477","CommonStockSharesConverted_0_Q2_shares":"175248847.0","CommonStockSharesOutstanding_0_Q2_shares":"175248847.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.21","EarningsPerShareBasic_2_Q2_USD":"-0.31","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-61663000.0","NetIncomeLossConverted_1_Q2_USD":"-36833000.0","NetIncomeLossConverted_2_Q2_USD":"-53123000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q2_USD":"317448000.0","RevenuesConverted_2_Q2_USD":"621193000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"2795579000.0","Ticker":"BMRN","filed":"20170802","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20170630","qtrs":"0","uom":"USD"}]